LRRK2 and Parkinson disease: To address our hypothesis, we screened a cohort of individuals with PD and age-matched healthy controls (HCs) using peptide pools targeting several PD-associated proteins (PINK1, LRRK2, parkin, GBA, SOD1, and OGDH) and measured the resulting T cell responses.